Autoimmune interactions between the HLA-DQβ157 polymorphism, T cell receptors, and microbial mimics of insulin in type 1 diabetes

Arcadio Rubio Garcia,Athina Paterou,Rebecca D. Powell Doherty,Laurie G. Landry,Mercede Lee,Amanda M. Anderson,Claire L Scudder,Hubert Slawinski,Ricardo C. Ferreira,Dominik Trzupek,Agnieszka Szypowska,Linda S. Wicker,Luc Teyton,Nicola Ternette,Maki Nakayama,John A. Todd,Marcin L. Pekalski

DOI: https://doi.org/10.1101/2022.05.11.22274678

2024-08-06

Abstract:Insulin autoimmunity and pancreatic islet β-cell destruction, mediated by T cells, underlie the pathogenesis of type 1 diabetes (T1D). However, the mechanisms by which genetic and environmental risk factors interact to cause T1D remain incompletely understood. Here, we show how variation in the human leukocyte antigen (HLA) class II region, notably DQβ157, the strongest T1D genetic risk factor, induces a positive thymic selection bias that favors amino acid motifs with negatively charged side chains in the peptide-binding CDR3β region of CD4+ T cell receptors (TCRs). This bias was enriched in TCRs from T1D patients and predicted the proportion of anti-insulin infiltrates in pancreatic islets. We link host genetics and immunity to the environment by identifying over 100 gut bacterial proteins with significantly similar sequences to a primary epitope in T1D, insulin B9-25 peptide. We show that CD4+ T cells isolated from the pancreas of a newly diagnosed child with T1D recognised both insulin and a bacterial mimotope peptide, restricted by the most predisposing DQ molecule. Our results point to the evolution of certain microbial antigens towards mimicry in the regulation of immune tolerance to insulin.

Allergy and Immunology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how the variation in the human leukocyte antigen (HLA) class II region, especially the DQ β1 57 polymorphism, affects the selection of T - cell receptors (TCR) during the thymic selection process, and then, in combination with the interaction with microbial - mimicking insulin molecules, jointly leads to the occurrence of type 1 diabetes (T1D). Specifically, the paper focuses on the following aspects:

1. **The relationship between genetic factors and the immune system**: The paper studied the genetic variation in the HLA class II region, especially the polymorphism at the DQ β1 57 site, and how it affects the amino acid motifs in the peptide - binding CDR3 β region of CD4+ T - cell receptors (TCR) through thymic positive selection bias, especially those amino acid motifs with negatively charged side chains.

2. **The role of environmental factors**: The paper explored how environmental factors, especially the gut microbiome, affect the immune tolerance to insulin through the molecular mimicry mechanism. The authors identified more than 100 gut bacterial proteins that are significantly similar in sequence to the major epitope B 9 - 25 of insulin, indicating that these microbial antigens may play a key role in regulating insulin immune tolerance.

3. **T - cell cross - reactivity**: The paper showed that CD4+ T cells isolated from the pancreas of newly diagnosed T1D children can recognize both insulin and a bacterial - mimicking peptide simultaneously. This indicates that some CD4+ T cells have cross - reactivity to insulin and bacterial peptides, and this cross - reactivity may be mediated by the most susceptible DQ molecules.

4. **Integrated mechanism**: The paper proposed a specific biological mechanism that links the major genetic risk factors (HLA class II - TCR interaction) and environmental risk factors (insulin epitope mimicry in the gut microbiome), explaining how these interactions increase the frequency of T cells that can recognize insulin and bacterial peptides, thereby leading to the occurrence of T1D.

In summary, this paper aims to reveal how genetic and environmental factors work together to affect the selection and function of T - cell receptors, leading to the occurrence and development of type 1 diabetes. This research helps to gain a deeper understanding of the pathogenesis of T1D and provides new ideas for future disease prevention and treatment.